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Abstract
Background: Progesterone Receptor Membrane Component 1 (PGRMC1) is expressed in many cancer cells, where
it is associated with detrimental patient outcomes. It contains phosphorylated tyrosines which evolutionarily
preceded deuterostome gastrulation and tissue differentiation mechanisms.
Results: We demonstrate that manipulating PGRMC1 phosphorylation status in MIA PaCa-2 (MP) cells imposes
broad pleiotropic effects. Relative to parental cells over-expressing hemagglutinin-tagged wild-type (WT) PGRMC1-
HA, cells expressing a PGRMC1-HA-S57A/S181A double mutant (DM) exhibited reduced levels of proteins involved
in energy metabolism and mitochondrial function, and altered glucose metabolism suggesting modulation of the
Warburg effect. This was associated with increased PI3K/AKT activity, altered cell shape, actin cytoskeleton, motility,
and mitochondrial properties. An S57A/Y180F/S181A triple mutant (TM) indicated the involvement of Y180 in PI3K/
AKT activation. Mutation of Y180F strongly attenuated subcutaneous xenograft tumor growth in NOD-SCID gamma
mice. Elsewhere we demonstrate altered metabolism, mutation incidence, and epigenetic status in these cells.
Conclusions: Altogether, these results indicate that mutational manipulation of PGRMC1 phosphorylation status
exerts broad pleiotropic effects relevant to cancer and other cell biology.
Keywords: Mitochondria, Migration, Invasion, Metabolism, Cytochrome P450, Mesenchymal amoeboid transition,
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Summary statement
PGRMC1 phosphorylation site mutations cause pleio-
tropic plasticity-related changes including altered mito-
chondrial form and function, PI3K/AKT activity,
migration, and glucose consumption. Efficient mouse
xenograft tumor formation required Y180.
Background
Progesterone (P4) Receptor Membrane Component 1
(PGRMC1) is a cytochrome b5-related heme-binding
protein with multiple functions including interaction
with cytochrome P450 enzymes. Briefly, (the reader is
referred to previous reviews) non-comprehensive
PGRMC1 functions include membrane trafficking, P4
responsiveness and steroidogenesis, fertility, lipid
transport, neural axon migration, synaptic function, and
anti-apoptosis. Its subcellular localization can be cyto-
plasmic, nuclear/nucleolar, mitochondrial, endoplasmic
reticulum, cytoplasmic vesicles, or extracellular [1–3]. It
is involved in cell cycle processes at the G1 checkpoint
and during mitosis [4–9], and elevated PGRMC1 expres-
sion has been associated with poor prognosis in multiple
types of cancer [2, 10–15].
Predicted binding site motifs for Src homology 2
(SH2) and Src homology 3 (SH3) proteins in PGRMC1
can potentially be negatively regulated by phosphoryl-
ation at adjacent casein kinase 2 (CK2) consensus sites
[2, 16, 17]. However, while CK2 knockdown leads to re-
duced phosphorylation of the corresponding C-terminal
CK2 site of PGRMC2, PGRMC1 phosphorylation at
S181 was unaffected by CK2 knockout in C2C12 mouse
myoblast cells [18]. These and Y180 can all be phos-
phorylated in vivo, and constitute a potential regulated
signaling module [19].
We hypothesized that PGRMC1 is a signal hub protein
with wide ranging effects on cell biology [2, 19–21]. The
highly conserved motif at Y180/S181 phosphorylation
arose early in animal evolution concurrently with the
embryological organizer of gastrulation (e.g. Spemann-
Mangold organizer), and prior to the evolution of deute-
rostomes [20, 22]. Since all of the descendants of the
organism that first acquired S181 exhibit bilateral body
symmetry, this mutation predated the rules governing cell
growth and division leading to bilateral body plan and
more types of tissues. The mechanisms that generate and
maintain cell- and tissue-type differentiation states are
very often perturbed in cancer [23]. Therefore, PGRMC1
tyrosine phosphorylation could potentially strongly in-
fluence mammalian cell function and differentiation status.
This present study was prompted by our discovery of
differential PGRMC1 phosphorylation status between es-
trogen receptor-positive and -negative breast cancers
[24]. PGRMC1 was induced in the hypoxic zone of
ductal carcinoma in situ breast lesions at precisely the
time and place that cells require a switch to glycolytic
metabolism known as the Warburg effect, leading us to
predict a Warburg-mediating role for PGRMC1.
Furthermore, a PGRMC1 S57A/S181A double CK2 site
mutant (DM, Fig. 1a) enabled the survival of peroxide
treatment [24]. Sabbir [25] recently reported that
PGRMC1 induced a P4-dependent metabolic change re-
sembling the Warburg effect in HEK293 cells, which was
associated with changes in PGRMC1 stability, post-
translational modifications, and subcellular locations.
PGRMC1 regulation of glucose metabolism is supported
by its implicated mediation of the placental P4-
dependent shift from aerobic towards anaerobic glucose
metabolism in gestational diabetes [26], association with
the insulin receptor and glucose transporters [27], and
probable involvement (based upon AG-205 sensitivity)
in P4-mediated increase in neuronal glycolysis [28].
We previously observed that MIA PaCa-2 pancreatic
cancer (MP) cells [29–32] exhibited marked morpho-
logical and metabolic changes when the DM protein was
expressed [33]. MP cells exist in culture as a mixed ad-
herent population of elongated “fibroblast-shaped”
morphology, a minority population of rounded morph-
ology with bleb-like protrusions, and some multicellular
clumps, as well as some rounded suspension cells. They
have undergone epithelial-mesenchymal transition [34],
and can further undergo mesenchymal-amoeboid
transition (MAT), which requires Rho Kinase- (ROCK)-
dependent morphological change from “elongated”
mesenchymal cells to rounded amoeboid cells [35].
Here, we mutagenically examined the effects of altered
PGRMC1 phosphorylation status on MP cells to gain
insights into PGRMC1-dependent signaling in vitro, re-
vealing an important role for Y180. Our objectives were
to initially characterize the effects of mutations at the
two DM putative negative regulatory phosphorylation
sites, S57 and S181, on cell biology, as well as mutating
Y180 which forms the center of a putative SH2 target
motif to test the hypothesis that the DM effect required
Y180. Importantly this investigation was extended to an
in vivo system, specifically a subcutaneous mouse
xenograft tumorigenesis model, in order to address the
requirement of Y180 for tumor development in a com-
plex environment. In a companion publication [36], we
describe differences in metabolism, genomic mutation
rates, and epigenetic genomic CpG methylation levels
associated with the PGRMC1 phosphorylation mutants
described in this present study.
Results
PGRMC1 phosphorylation status alters cellular
morphology
We stably transfected MP cells with the hemagglutinin
(HA) epitope-tagged PGRMC1-HA plasmids including
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the wild-type (WT) sequence [37], the S57A/S181A DM
[24], or a novel S57A/Y180F/S181A triple mutant (TM),
which removed the phosphate acceptor of Y180 [16, 19,
20] (Fig. 1a). Three independent stable cell lines from
each group expressed both 32 kDa 3xHA-tagged exogen-
ous and a 24 kDa endogenous PGRMC1 species, whereas
only the 24 kDa species was present in MP cells (Fig. 1b-
d). Both species were present at approximately equimo-
lar ratios, and an anti-HA antibody detected only the 32
kDa species (Fig. 1d). We reason that any consistent
differences between biological triplicates should be due
to PGRMC1-HA mutations, rather than clonal artifacts.
Fig. 1 MIA PaCa-2 pancreatic cancer cells morphology is affected by PGRMC1 phosphorylation status. a PGRMC1-HA proteins constructed for this figure.
TMH: Trans-membrane helix. HA: the C-terminal 3x hemaglutinin tag. b Detection of exogenous PGRMC1 expression levels by western blot (upper panel).
Equal loading is controlled by quantifying beta actin (lower panel). The results show three totally independent stably transfected cell lines per plasmid
from (A). Open arrow: Exogenous PGRMC1-HA (Ex.). Shaded arrow: endogenous PGRMC1 (End.). Filled arrow: beta actin. The molecular weight ladder is
Bio-Rad 1610377 Dual Xtra Standards. c Box plots quantification of replicate gels of (B) with signals normalized to beta actin from the same respective
lanes. n= 4 lanes for MP and n= 6 for WT, DM and TM (replicates of respective lines 1–3 per condition). There were no significant differences (ns) except
for the exogenous band in MP (ANOVA, post-hoc Dunnet’s T3). dWestern blot quantification of HA-tagged exogenous PGRMC1, following B but detecting
PGRMC1 with anti-HA antibody. The molecular weight ladder is Abcam ab116028 Prestained Protein Ladder. e PGRMC1 mutant protein expression alters
MIA PaCa-2 cell morphology. PGRMC1-HA-expressing stable cells (respective lines 1 from B) or MP cells were stained with a FITC-tagged anti-HA antibody
(Anti-HA) and imaged by confocal microscopy. DNA was stained with DAPI. Cells were also imaged in differential interference contrast (DIC) microscopy
mode. The respective left panels show merged images of all 3 channels. f The rounded phenotype of double and triple mutant (E) was reversed to
elongated phenotype after 125 μM ROCKI addition, but not by addition of DMSO vehicle control
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Subsequent experiments were performed using re-
spective cell line triplicates 1–3 per PGRMC1-HA
condition. However, note that MP cells have not
undergone hygromycin selection for stably-integrated
plasmids, therefore cells in the WT/MP comparison
differ by two variables (selection and PGRMC1-HA).
We focus our analysis onto comparisons between
WT, DM and TM cells.
Like MP cells, freshly seeded WT cells exhibited
predominantly elongated cell morphology with some
rounded cells. DM and TM cells exhibited primarily
rounded morphology (Fig. 1e), which was reminiscent of
the reported MAT of MP cells [35]. After 72 h of culture
the proportion of round cells in DM and TM cultures
was reduced, but still elevated relative to WT or MP
(not shown). Transient transfections with the DM and
TM plasmids (but not WT) led to similar increased
levels of cell rounding across the entire populations of
cells by 24 h after transfection (data not shown), indi-
cating that the phosphorylation status of exogenous
PGRMC1-HA affects cell morphology.
PGRMC1-dependent altered morphology requires rho
kinase
The ROCK pathway is required for amoeboid phenotype
and migration and its inhibition reverses MAT in MP
cells [35, 38]. ROCK inhibitor (ROCKI) reversed the
rounded phenotype to elongated for DM and TM (Fig.
1f), supporting the hypothesis that morphological transi-
tion involves altered actin organization. It remains
unclear whether the process is truly MAT.
PGRMC1 phosphorylation affects cell motility and
invasion
To further investigate cell plasticity imposed by
PGRMC1-HA phosphorylation mutants, we examined
cell motility via a scratch assay [39]. MP cells exhibited
the lowest migration, while DM cell migration was sub-
stantially greater than other cell lines (Fig. 2a-b, File S1).
DM cells migrated predominantly as rounded cells, using
extended filopodia and small pseudopodia, however, a mi-
nority of flattened cells exhibited more pronounced
pseudopodia. Video imaging demonstrated that these cell
shapes could rapidly interconvert (File S1C). Conversely,
DM cells exhibited the lowest ability to invade through a
Geltrex pseudo-basal membrane (Fig. 2c-d).
PGRMC1 phosphorylation imposes broad changes
A total of 1330 proteins were reliably identified by pro-
teomics in at least one sample with at least 2 peptides
using a combination of information dependent acquisi-
tion (IDA) and data independent SWATH-MS (Sequen-
tial Window Acquisition of all Theoretical Mass
Spectrometry) acquisition. Results are provided as File
S2. Approximately 50% of variation was explained by
two principal components (PCs) in PC analysis, which
corresponded approximately to “ribosomes and trans-
lation” (PC1, separated MP&DM from WT&TM) and
“mRNA splicing and processing” (PC2, separated
MP&WT from DM&TM) (Fig. S1A, File S3). Of the
identified proteins, 243 differed by 1.5 fold or more be-
tween one or more comparisons with p < 0.05 (t-test),
and 235 of these withstood PC multiple sample correc-
tion. The heat map clustering of those 243 proteins
(Fig. 3, File S6) revealed a suite of proteins which
strongly discriminated between the different PGRMC1-
HA-induced conditions. Biological replicates clustered
tightly in clades of the same cell type, with large
distances between clades. We conclude that these
differences are primarily specific PGRMC1-HA mutant-
dependent effects.
Results from those six comparisons of protein abun-
dance between the four sample types [1) MP v. WT, 2)
MP v. DM, 3) MP v. TM, 4) WT v. DM, 5) WT v. TM,
and 6) DM v. TM] provide lists of significantly differen-
tially abundant proteins in each pair-wise comparison
(File S2). WebGestalt enrichment analyses were per-
formed to identify pathways or features either signifi-
cantly more or less abundant (respectively the “red” and
“blue” lists of proteins for each comparison from col-
umns B of File S4) between each of the respective six
comparisons at the Benjamini–Hochberg adjusted p-
value (adjP) < 0.001 level in at least one pairwise com-
parison. WebGestalt mapped features (File S5) are plot-
ted against the heat map in File S6 (for primary
WebGestalt data see File S5 and File S6). The results are
schematically mapped against the 243 protein heat map
in Fig. 3, using all pathways that were detected by Web-
Gestalt in any of the inter-sample comparisons at the
adjP< 0.001 level, and including all proteins detected in
any of those pathways across all 12 comparisons at the
adjP< 0.1 level for respective red and blue protein lists
from File S4.
WT PGRMC1-HA protein induced the elevated abun-
dance of many proteins involved in energy metabolism,
including proteasomal components involved in protein
degradation, and pathways for amino acid, carbohydrate,
and fatty acid catabolism (Fig. 3). These proteins were
annotated as both cytoplasmic and mitochondrial. Per-
oxisomal and lysosomal proteins were also upregulated
in WT cells. A suite of proteins putatively involved in
the recognition of mRNA by ribosomes, tRNA aminoa-
cylation, ribosomal protein translation, and chaperone-
mediated protein folding, was generally less abundant in
WT and TM than MP and DM cells (Fig. 3, File S6).
Many of the changes in fatty acid and glucose metabol-
ism enzymes resemble the effects of the insulin/glucagon
system of metabolic regulation.
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Many of the above proteins were inversely regulated in
the comparison of WT and DM cells (Fig. 3). The energy
metabolizing suite of proteins and some proteins associ-
ated with translation were less abundant in DM, whereas
the T-complex chaperone complex as well as some
nuclear exportins and importins were elevated in DM
cells (Fig. S1D-E). Some differentially enriched pathways
were specific for the WT vs. DM comparison. Different
enzymes associated with heme metabolism were both
up- and down-regulated while enzymes associated with
glycosaminoglycan metabolism were up-regulated in
WT relative to DM (Fig. 3, File S6).
Mitochondrial proteins accounted for a large percent-
age of the proteins more abundant in WT than DM
cells. Intriguingly, many cytoplasmic proteins were more
abundant in WT cells than DM (Fig. 3, File S6). We also
noted higher abundance components of ATP synthase in
WT and TM cells (Fig. S1C), changes of proteins
Fig. 2 PGRMC1 phosphorylation status affects motility and invasion. a DM cells exhibit enhanced motility in a scratch assay. Representative results
for the scratch assay after 36 h of cell migration. Cells in the boxed area of the scratched void area for each image were counted. b Scratch assay
cell migration results. Box plots of cell migration into the scratch void box areas depicted in (A) for multiple replicates. n = 12 (MP), or 4 replicates
each of sublines 1–3 for WT and TM (n = 3 × 4 = 12). The table shows the results of 1 way ANOVA with post-hoc Dunnet’s T3 p-values. Video files
of cell migration are available in File S1. c DM cells exhibit reduced invasion in Geltrex invasion assay. Representative images of crystal-violet
stained cells in the lower surface of the transwell insert. d Boxplots of invasion assay results from (C) for replicates, as produced by SPSS software.
n = 30 (MP), or 10 replicates each of sublines 1–3 for WT and TM (n = 3 × 10 = 30). The table shows the Kruskal-Wallis p-values for pairwise comparisons
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involved in chaperonin and microtubule function (Fig.
S1D), and a group of proteins involved in major histo-
compatibility complex antigen processing and presenta-
tion, and proteolysis (Fig. S1F). The latter are reduced in
DM cells and may be associated with their reduced inva-
siveness (Fig. 2c-d), which requires future confirmation.
Consideration of the extreme (highest and lowest
abundance) differential proteins for each cell type offers
useful insight into biology (Fig. S2). WT and TM cells
exhibited overlap in the subset of most abundant
proteins, which included PSIP1 transcriptional coactiva-
tor, TOM40 mitochondrial import channel, as well as
CDIPT which catalyzes the biosynthesis of phos-
phatidylinositol (circles in Fig. S2). One of the WT
abundant proteins was phosphofructokinase (UniProt
P08237), which catalyzes the rate limiting reaction and
first committed step of glycolysis. The most abundant
DM proteins included keratin 19, ubiquitin-associated
protein 2-like, which is involved in stem cell mainten-
ance [40], and methyl-CpG-binding protein 2, which
Fig. 3 Pathways analysis of SWATH-MS proteomics results. Pathways significantly enriched at the adjP> 0.001 level between all 6 comparisons of
“red” and “blue” differential proteins (red = higher abundance, blue = lower abundance, white = equal abundance). Top left: the proteomic heat
map of 243 significantly differential proteins. A color code for WebGestalt pathways is given at top right. Bottom: WebGestalt pathways mapping.
This image is derived from File S6, which contains all protein and WebGestalt pathway identities
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was more abundant in WT and TM cells, suggesting
PGRMC1-mediated changes in genomic methylation
(see accompanying paper [36]). The least abundant pro-
teins shared a surprising mixed overlap between cell
types (triangles in Fig. S2). TM and WT cells shared low
levels of Ephrin type-A receptor 2, a tyrosine kinase re-
ceptor, which was higher in DM (and MP) cells without
being a top abundant protein in those cells. WT exhi-
bited low levels of signal recognition particle 54 kDa
protein, suggesting altered translation of endoplasmic
reticulum proteins, and AL1A1 retinal dehydrogenase.
This was notable because both DM and TM exhibited
low levels of AL1A3 NAD-dependent aldehyde
dehydrogenase involved in the formation of retinoic
acid, suggesting alterations in retinoic acid metabolism
by mutating S57/S181. DM and TM also shared low
levels of ApoC3 and ApoA1 (Fig. S2), probably reflecting
common lower lipoprotein synthesis by those cells.
Taken together, our proteomics analysis revealed signifi-
cant differences in the abundance of enzymes involved
in diverse cell processes, many of which are directly
implicated in cancer biology. The resemblance of WT
and TM differential proteomics profiles suggests that the
DM mutation activates signaling processes that are
largely dependent upon Y180. (The sole difference be-
tween DM and TM proteins is the phosphate acceptor
Fig. 4 RPPA measurements of protein and phosphorylated protein levels. a-d, f-h Average RPPA normalized fluorescent intensity (NFI) from the
indicated antibodies (described in methods) is plotted from 6 replicate measurements. NFI is normalized to protein content. Statistical
calculations for normally distributed data were made using one way ANOVA, and post-hoc Bonferroni (BF) for equal variances (all variances were
equal). For non-parametric data, Kruskall-Wallis (KW) pairwise comparisons were calculated for 24 unrelated samples. * p < 0.05; ** p < 0.01, *** p <
0.001. Non-phosphorylated BAD levels could not be accurately determined because signal values were less than three times background. e The
ratio of average NFI of D relative to C. Labels follow the above
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oxygen of Y180). Overall, this study indicated that
PGRMC1 phosphorylation status exerts higher order
effects in MP cells. To assess the validity of the pathways
analysis, selected enriched pathways were functionally
examined, as described below.
ERR1 activity is not directly affected by PGRMC1
Some mitochondrial proteins associated with energy
metabolism were predicted by pathways enrichment ana-
lysis to be regulated by estrogen receptor related 1
(ERR1) transcription factor (Fig. S3A) in the compari-
sons of DM cells with both WT (adjP = 0.004) and TM
(adjP = 0.04) (File S4). Since ERR1 is a steroid receptor,
we investigated any potential link between the biology of
PGRMC1 and ERR1 by attenuating ERR1 levels in WT
cells by shRNA. This changed cell morphology from
predominantly elongated to rounded cells (Fig. S3B-D).
SWATH-MS proteomics revealed that ERR1 indeed
regulated genes differentially abundant between WT and
DM cells observed in Fig. S3A and Fig. 3. However,
PGRMC1 phosphorylation status affected the abundance
of only a subset of ERR1-driven proteins.
PGRMC1 phosphorylation affects PI3K/AKT signaling
Strikingly, proteins associated with PI3K/AKT activity
from Fig. 3 and File S6 were revealed by File S5 to ex-
hibit lower abundance in TM cells (Fig. S1B) relative to
MP (adjP = 0.0063), WT (adjP = 0.0001) and DM (adjP =
0.0002) cells. We assayed the phosphorylation status of
two AKT substrates by Reverse Phase Protein Array
(RPPA). BAD is phosphorylated by both PKA at S112
[41], and at S136 by AKT [42]. Whereas there was no
significant difference between BAD S112 phosphoryl-
ation between DM and TM (Fig. 4a), phosphorylated
S136 levels were lower in TM cells than in all other cells
(p < 0.001, Fig. 4b). It was not possible to reliably quan-
tify these levels relative to BAD itself since BAD signals
were too low (not shown). One of the best attested sub-
strates of AKT is glycogen synthase kinase 3 beta
(GSK3β), which is phosphorylated on S9 by Akt leading
to inactivation of GSK3β [43]. Levels of phosphorylated
GSK3β S9 were elevated in WT over MP cells, elevated
once more by removing the inhibitory CK2 sites in the
DM mutation, and reduced by the further mutation of
Y180 in TM mutant cells (Fig. 4c-e). These results
strengthen the model arising from pathways enrichment
Fig. 5 PGRMC1 phosphorylation status affects glucose uptake, lactate secretion, and mitochondrial function. a Glucose uptake by cell lines using
the Cayman “Glycolysis” kit. The boxplots represent four technical replicates each for each of independent stably transfected sub-lines 1–3 of each
condition WT, DM and TM (lines from Fig. 1). i.e. n = 4 × 3 = 12 per condition. For MP cells, 12 replicates of the MP cell line were performed. There
was significant difference between all means (Kruskal-Wallis p < 0.0001, pairwise two-sample Kolmogorov-Smirnov Tests p < 0.0002). b Lactate
secretion by cell lines. Details follow (A), except duplicates of each stable cell line were measured (n = 3 × 2 = 6 per condition). Inter cell-type
comparison tests revealed that the means of all pairwise comparisons were significantly different from one another (ANOVA, post-hoc Dunnet’s
T3, p < 0.003), except the WT-TM comparison which was not significant (p = 0.211). c The maximal respiratory capacity of mitochondria is affected
by PGRMC1 phosphorylation status. Mitochondrial oxygen consumption of respective independent clonal stable lines C1 of each PGRMC1-HA
mutant condition WT, DM and TM. Arrows indicate the time of addition of ATP synthase inhibitor oligomycin, Δψm uncoupler FCCP, and
electron transport chain inhibitors rotenone & antimycin A. OCR: oxygen consumption rate (pmol/min normalized per μg protein), n = 5;
mean +/− s.d.
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analysis, that PI3K/AKT pathway which is activated in
DM cells requires phosphorylated PGRMC1 Y180, and
is therefore attenuated in TM cells.
PGRMC1 phosphorylation affects FAK activation and HSF
levels
Pathways mapping (File S5) suggested that transcription
factor HSF1 activity could be involved in the difference
between WT v. DM (adjP = 0.006). HSF1 has been linked
with Focal Adhesion Kinase (FAK) activity [44], and
FAK activity is dependent upon Rho/ROCK signaling
which influences focal adhesion dynamics and tumor cell
migration and invasion [45]. RPPA measurements
showed that FAK1 tyrosine phosphorylation and in-
creased HSF1 levels were all significantly elevated in WT
and TM (Fig. 4f-h). Notably, this profile resembled the
differential proteomics profile of Fig. 3, rather than the
ROCK-dependent rounded morphology of Fig. 1d, and
once more provided validation of a pathways prediction.
Notably, whereas FAK activity has been associated with
increased motility [45], its phosphorylation did not differ
significantly between WT and DM cells, which exhibited
altered motility. Elevated FAK phosphorylation in TM
cells, which exhibited lower migration than DM, could
possibly be due to feedback regulation onto FAK. The
basis for this merits future investigation, however pre-
sumably reflects an impingement of PGRMC1 phosphor-
ylation status on the migratory process.
Vinculin elevated in DM is required for cell motility
Proteins of the actin cytoskeleton were more abundant
in DM cells (Fig. S4A), one of which was vinculin (Fig.
S1B), an actin filament-binding protein associated with
cell differentiation status, locomotion, and PI3K/AKT,
E-cadherin, and β-catenin-regulated WNT signaling in
colon carcinoma [46, 47]. We attenuated vinculin levels
in MP, WT, and DM cells via shRNA. Scrambled shRNA
control (shScr) DM cells exhibited elevated scratch assay
motility relative to MP cells. However in anti-vinculin
shRNA (shVCL) cells, both MP and DM cell motility
was reduced (Fig. S4). These results are consistent with
elevated levels of proteins involved in the actin cytoske-
leton (Fig. S4A) contributing directly to the enhanced
motility of DM cells (Fig. 1f-g). However, that hypothesis
remains untested except for vinculin. Future studies
should examine the effect of PGRMC1 signaling on actin
cytoskeleton properties.
PGRMC1 affects glucose metabolism
Figure 3 predicted altered glycolysis activity, which we
investigated by glucose uptake and lactate production as-
says. Expression of all PGRMC1-HA proteins (WT, DM,
and TM) led to significantly lower levels of both mea-
sures relative to MP, with DM cells exhibiting the lowest
levels (Fig. 5a-b). It is unclear whether the MP/WT dif-
ference is due to PGRMC1-HA expression or to the
hygromycin selection of WT cells. However, for the
other cells PGRMC1 phosphorylation status regulates
both features, consistent with recently reported regula-
tion of Warburg metabolism by PGRMC1 [25], which
our data indicates can be regulated by PGRMC1 phos-
phorylation status.
PGRMC1 phosphorylation affects mitochondrial function
Figure 3 also implied that mitochondria may be affected
by PGRMC1 phosphorylation status. Naphthalimide-
flavin redox sensor 2 (NpFR2) is a fluorophore targeted
to the mitochondrial matrix. Its fluorescence is elevated
approximately 100-fold when oxidized, providing an
assay for mitochondrial matrix redox state [48]. NpFR2
revealed that the matrix of WT and TM cells was more
oxidizing than MP and DM cells (Fig. S5A, B), which
corresponded with the elevated expression of many
nuclear-encoded mitochondrial proteins in Fig. 3.
We then examined mitochondria using the fluorescent
marker MitoTracker, whose affinity for mitochondria is
affected by mitochondrial membrane potential (Δψm)
[49]. Flow cytometry revealed the presence of two popu-
lations of MitoTracker-binding cells in each cell type:
low and high MitoTracker-binding (Fig. S5C-E). These
populations were about equal for MP, WT, and TM
cells, however, DM cells exhibited overall lower relative
fluorescence level in each population Fig. S5C-D) and a
higher proportion of cells with higher MitoTracker bind-
ing (Fig. S5C,E). Notably, higher levels of mitochondrial
proteins in WT and to some extent TM cells apparently
did not correspond with higher Δψm caused by actively
respiring mitochondria.
Relative to MP cells, the maximal respiratory rate was
reduced (between 2 and 3 fold in Fig. 5c) by expression
of DM or WT PGRMC1-HA, but not TM cells (Fig. 5c).
The relative profiles of basal (Fig. S5F) and maximal
(Fig. S5G) respiratory rates for WT and DM cells were
similar, with TM cells exhibiting rates intermediate to
those of MP. This profile was observed on three inde-
pendent comparisons WT/DM/TM. The single ex-
periment including MP is shown. We conclude that
the altered abundance of mitochondrial proteins
due to PGRMC1 phosphorylation status detected in
Fig. 3 was accompanied by altered mitochondrial
function. However, the relationship is not as simple
as lower glucose uptake being associated with
higher mitochondrial oxygen consumption, or
NpFR2 redox status (a function of the rates of
superoxide leakage from complex IV, and antioxi-
dant defense systems [50]) and may involve alter-
ations in mitochondrial permeability to protons or
other uncoupling mechanisms, for instance by
Thejer et al. BMC Molecular and Cell Biology           (2020) 21:24 Page 9 of 24
altered cholesterol content [21], and/or altered elec-
tron transport chain properties. This result clearly
reveals an important area requiring further study
that was revealed by our proteomics study.
PGRMC1 phosphorylation affects mitochondrial
morphology and function
Mitochondria were further explored by measuring mito-
chondrial content (area per cell), size (perimeter), and
Fig. 6 PGRMC1 phosphorylation influences mitochondrial and cell morphology together. a Images show cells with close to average form factor (avFF) values
for elongate or rounded cells of each cell type. The numbers of cells scored in each class are indicated. All cell images are reproduced to the same scale.
b Elongated and round cells from (a) examined according to cell type. The top left panel shows average percentage elongated cells scored for three
independent biological replicate cell lines per cell type across all 3 replicates (n(Σ1–3)) corresponding to the given n values in (A). The remaining panels showing
the distribution of cells in each shape and type category of Area, Perimeter and FF. Kruskal-Wallis analysis revealed no significant differences at the p< 0.05 level
between any elongated cell type comparisons (ns), whereas all cell types exhibited significant differences for round cells (Kruskal-Wallis, P< 0.001). The
accompanying Kruskal-Wallis post-hoc pairwise comparison p-values for round cells are given in the respective Tables. c AvFF per cell plotted including cell
shape. The values where cells transition between round and elongated morphology (avFF 2.2–2.6) are indicated by dotted lines
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morphology, or form factor (FF). FF is a parameter de-
rived from individual mitochondrial area and perimeter,
where higher values correspond to a greater degree of
filamentous than fragmented mitochondria [51, 52].
Representative images of mitochondria are shown in
Fig. 6a. Numbers of mitochondria per cell varied greatly,
with no significant differences detected between cell
types (not shown). Over the entire data set, elongated
cells exhibited greater mitochondrial area, larger mito-
chondria, and greater average FF (avFF) (Kolmogorov-
Smirnov p < 0.0001; not shown). When analyzed accord-
ing to PGRMC1 status (cell type), MP and WT cells
were predominantly elongated, and DM and TM were
predominantly rounded, as expected (Fig. 6a-b). We
detected no significant differences in average mitochon-
drial area, perimeter or avFF between cell types for
elongated cells, however rounded cell types exhibited
significant differences between the cell types for area,
perimeter, and avFF (Fig. 6b). All cells with avFF < 2.2
exhibited rounded cell shape, while all cells with avFF
> 2.6 exhibited elongated shape (Fig. 6c). The observed
avFF-associated transition from round to elongated cell
shape was discrete for all cells except WT, occurring at
avFF = 2.4 (MP), 2.2–2.6 (WT), 2.7 (DM) and 2.6 (TM).
Notably, the single elongated TM cell also exhibited the
highest avFF value for TM (Fig. 6c). Holo-tomographic
time-lapse videos [53] for each cell type show live
mitochondria (File S7). PGRMC1 phosphorylation status
probably influences mitochondrial content, size, and FF
(degree of filamentation) by the same mechanisms that
affect cell shape, consistent with the proposed influence of
cytoskeleton on mitochondrial morphology and function
[54]. We conclude that our proteomics pathways analysis
revealed biologically relevant functional differences in
mitochondria, once more indicating a new area that
requires further research.
PGRMC1 Y180 is required for subcutaneous mouse
xenograft tumor growth
No significant differences in cell proliferation between
cell types were observed in culture IncuCyte imaging
(Fig. 7a), or repeated MTT assays (not shown). We
established subcutaneous xenograft tumors in replicate
mice carrying each of sub-lines 1–3 of WT, DM and
TM (e.g. 4x line 1, 3x line 2, 3x line 3, n = 13 per
PGRMC1-HA condition), as well as n = 5 mice with cells
expressing the single Y180F mutant [24], or MP cells.
Tumors produced by both TM and Y180F cells were
significantly smaller than those produced by WT or DM
cells (Fig. 7b-c), indicating that PGRMC1 Y180 was
required for optimal tumor growth, and demonstrating
that the cellular responses to altered PGRMC1 phos-
phorylation strongly influences cancer biology. All WT,
DM, TM and Y180F tumor tissue expressed the
PGRMC1-HA proteins (not shown), and therefore arose
from the injected cells. There were no obvious differ-
ences in histology between cell types based upon
hematoxylin and eosin staining (not shown).
Fig. 7 PGRMC1 Y180 contributed to growth of subcutaneous mouse
xenograft tumors. a There are no differences in cell doubling time in
culture. Replicates of stable cell lines 1–3 for each condition were
measure to give n = 6. There were no significant differences between
cell conditions. b Typical tumors produced by each respective class of
cell. c Box plot of the distribution of tumor sizes among mice injected
with 2 × 106 cells of each of the cell lines. For WT, DM and TM the
results depict 4x each of lines 2 and 3, and 5 mice from line 1. MP and
Y180F each represent 5 replicates of a single cell line. The box shows
pairwise post-hoc Dunnet’s T3 p-values after one way ANOVA
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Discussion
We report new biology associated with the phosphoryl-
ation status of PGRMC1-HA proteins from Fig. 1a,
which profoundly affected cell morphology and migra-
tory behavior. The morphotypic change from WT to
DM resembled MAT in MP cells, being sensitive to
ROCKI (Fig. 1d). The DM and TM altered morphology
is dependent upon activated ROCK, which leads to stiff-
ening of cortical actomyosin [55]. In human glioma cells
over-expression of CD99 is implicated in MAT, resulting
in rounded morphology, increased Rho activity, and en-
hanced migration [56]. These properties superficially re-
semble the phenotype of our DM cells (Fig. 1e-f),
however DM cell migration involved pseudopodia and
cell adhesion, as evidenced in cell migration videos (File
S1). Very little else is known at the molecular level about
the events that promote MAT and altered cell motility
[57–60]. We provide here a global proteomics expres-
sion study of a possibly MAT-related process, and show
that PGRMC1 phosphorylation status dramatically
affects cell morphology and behavior.
Proteomics pathways enrichment analysis suggested
that PGRMC1 also influenced mitochondria, leading us
to detect altered function and morphology (Fig. 6). It
was previously shown that PGRMC1 co-evolved with a
suite of mitochondrial proteins [21]. The elongated cell
morphology that predominated in MP and WT cells was
associated with a higher index of filamentous rather than
fragmented mitochondria. Cells with rounded morph-
ology and more fragmented mitochondria predominated
in DM and TM cells (Fig. 6). Such changes in mitochon-
drial function are driven by altered relative rates of mito-
chondrial fission and fusion, leading to mitochondrial
fragmentation or elongated hypertubulation, respectively
[61]. Fragmented mitochondria are associated with
pathological conditions including cardiovascular and
neuromuscular disorders, cancer, obesity, and the
process of aging, associated largely with altered cell dif-
ferentiation [61]. One of the proteins more abundant in
WT and TM cells was Opa1 (O60313) (File S6), a protein
known specifically to regulate mitochondrial fission/fusion,
and one that has been reported to interact directly with
PGRMC1 [62]. This suggests areas of future research.
The strongest driver of mitochondrial morphology
appears to have been cell shape, or vice versa (Fig. 6).
The cytoskeleton is thought to influence mitochondrial
function and morphology [54], and proteomics pathways
mapping suggested cytoskeletal changes. WT cells had
elevated levels of Tubulin 1alpha (Q71U36), and de-
creased levels of Tubulin alpha-1C (Q9BQE3), Tubulin
beta-2A chain (Q13885), Tubulin beta-4B chain
(P68371) (Fig. S1E) relative to DM cells. Rounded DM
cells exhibited more abundant type II cytoskeletal kera-
tin 8 (P05787), type I cytoskeletal keratin 18 (P05783),
and type I cytoskeletal keratin 19 (P08727) relative to
MP cells (which are epithelial markers [63]), with WT
and TM cells exhibiting intermediate keratin levels (see
File S6 associated with Fig. 3). These keratin abundance
profiles paralleled the elevated levels of proteins in an
enriched actin cytoskeleton pathway in DM cells (Fig.
S1B). We have recently demonstrated that many pro-
teins related to the actin cytoskeleton are co-
immunoprecipitated with PGRMC1 in MP cells [64],
and that the PGRMC1 membrane-associated progester-
one receptor (MAPR) family cytochrome b5 domain
contains a region of predicted coiled-coil formation that
resembles regions from several myosins [22], consistent
with an influence of PGRMC1 on actin-related functions
and interacting with proteins that interact with myosins.
DM cells also displayed elevated levels of proteins in the
T-complex protein-1 ring complex (TRiC, also known as
CCT) (Fig. S1E), which contributes to folding of proteins
including actin and microtubules, and influences deregu-
lated growth control, apoptosis, and genomic instability
[65, 66]. TRiC additionally contributes to obligatory
growth/survival functions in breast [67] and liver [68] can-
cers. TCP1 (P17987, Fig. S1E) expression is driven by
oncogenic PI3K signaling in breast cancer [67], and we
observe both elevated PGRMC1-dependent PI3K/AKT
activity and TRiC abundance in DM cells (Fig. S1E).
In summary, many of the mitochondrial differences
observed could be attributable to altered cytoskeletal
properties. However, the differential mitochondrial func-
tions of Fig. 5 and Fig. S5 did not correspond well with
cell shape, indicating that PGRMC1 also changes com-
plex causative processes driven by more than mitochon-
drial morphology. In this context, we note the recent
observation that PGRMC2 mediates heme shuttling to
the nucleus of adipocytes, leading to altered transcrip-
tion of genes encoding mitochondrial proteins [69]. It is
possible that PGRMC1 exerts related effects in these
cells, which merits future study.
Results depicted in Fig. 3 (as presented in File S5 and
File S6) revealed that both the ATP synthase subunit
beta of the F1 catalytic domain as well as the F0 proton
pore domain were up-regulated in WT cells relative to
DM cells (Fig. S1C). It is possible that the higher Δψm
of DM cells is related to low levels of F0/F1 ATPase pro-
ton channels (Fig. S1C), resulting in relatively inefficient
proton gradient clearance. Mitochondrial cholesterol de-
creases the permeability of the inner membrane to pro-
tons, increasing the efficiency of electron transport chain
yield [21]. Altered metabolism could be due to activity
of the PI3K/AKT pathway, suggesting direction for fur-
ther work that will be required to explain the mecha-
nisms underlying the observed responses.
Loss of PGRMC1 affects the SREBP-1/fatty acid
homeostasis system [70], and PGRMC1 influences cell
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surface localization of insulin receptor and glucose
transporters [27]. Chemical proteomics showed that
PGRMC2 but not PGRMC1 promotes adipogenesis in 3
T3-L1 preadipocytes following a gain of function inter-
action with a novel small molecule which displaced
heme [71]. It will be interesting to examine whether that
treatment mimics the effects of phosphorylation.
(PGRMC2 possesses cognates to PGRMC1 Y180 and
S181, as well as heme-chelating Y113 [20].)
Our results indicate that PI3K/AKT signaling in DM
cells required PGRMC1 Y180, which was the sole differ-
ence to TM cells. PGRMC1 has long been recognized as
a modulator of AKT activity, with cell type-specific ef-
fects [24, 27, 72–76]. This predicted activation of signals
by removal of the putative inhibitory CK2 consensus
sites in the DM protein [19, 24] was dependent upon
Y180 because TM (which differs from DM by a single
oxygen atom) exhibited a protein expression profile that
was more similar to WT than DM (Fig. 3). Furthermore,
our in vivo studies evaluating the growth of subcutane-
ous tumors confirmed the importance of Y180 in an in-
tact biological system thus supporting and extending our
in vitro observations to reveal the central importance of
Y180 (Fig. 7). Because of the high conservation of Y180
in eumetazoan animals [22], these results are likely to
bear relevance to other species, and multiple human
diseases [2]. In a methylomics study of these cells in the
companion paper, the most significantly down-regulated
KEGG pathway in the TM/DM comparison was PI3K-
AKT [36], consistent with PI3K/AKT activation requir-
ing PGRMC1 Y180, which was required for tumor
growth (Fig. 7).
Interestingly, PGRMC1 knockdown in human pluripo-
tent stem cells (hPSCs) led to an increase in GSK3β in-
hibitory phosphorylation [77]. Examination of PGRMC1
phosphorylation status in that system is merited, where
PGRMC1 suppressed the p53 and WNT pathways to
maintain hPSC pluripotency. Similarly to our results,
those authors concluded “that PGRMC1 is able to sup-
press broad networks necessary for multi-lineage fate
specification.” Our hypothesis suggests that PGRMC1
Y180 phosphorylation and PI3K/AKT activity could be
associated with elevated GSK-3β Ser9 phosphorylation and
β-catenin signaling as observed in in some cancers [47].
Our initial hypothesis related to differential phosphor-
ylation of PGRMC1, being potentially spatially and tem-
porally associated with regulation of the Warburg effect
[24]. It is notable that the Warburg effect resembles a
reversion to stem-cell-like metabolism [78]. While this
manuscript was in preparation, Sabbir showed that
PGRMC1 post-translational modification status in
HEK293 cells responds to P4 treatment, which was ac-
companied by a PGRMC1-dependent increase in gly-
colysis [25]. Our cells exhibited a large reduction in
glycolysis between MP and WT cells, which may be due
to either PGRMC1-HA expression or to hygromycin
stable selection of WT cells. However phosphorylation
state differences between WT, DM and TM elicited
marked differences in both glucose consumption and
lactate secretion (Fig. 5). It is important to note that en-
dogenous PGRMC1 is expressed in all of these cells, and
so we cannot determine to what extent these mutated
proteins may elicit effects on their own, or interfere with
endogenous PGRMC1. However, we conclude that
PGRMC1 can modulate glycolysis, in line with our hy-
pothesis, although the mechanism requires further re-
search which should examine the possibility that PI3K/
AKT activity elevated in DM cells negatively regulates
the Warburg effect.
Conclusion
The phospho-acceptor amino acid Y180 has been con-
served in PGRMC1 proteins since the evolutionary ap-
pearance of the differentiation-inducing gastrulation-
organizer [22]. We therefore believe it likely that
the PGRMC1 Y180-regulated modulation of metabolic
and growth control that we have manipulated could re-
present a major newly identified foundational axis of
animal cell biology, whose perturbation is inconsistent
with the maintenance of differentiated states acquired
during the subsequent evolution of complex body plans.
Although we can confidently deduce the existence of a
PGRMC1 signal network, as yet we have identified nei-
ther immediate upstream PGRMC1 effectors nor down-
stream targets. In a companion study [36], we show that
the cells characterized in this paper differ dramatically in
genomic methylation and mutation rates. Future studies
should urgently explore the relationship between
PGRMC1 signaling and diseases such as cancer, diabetes,
Alzheimer’s disease, and others [2].
Methods
Plasmid preparation
Plasmids pcDNA3.1-PGRMC1-HA (wild type: WT),
pcDNA3.1-PGRMC1-HA_Y180F (Y180F), pcDNA3.1-
PGRMC1-HA_S57A/S181A (double mutant, DM) and
pcDNA3.1-PGRMC1-HA_Y180F (Y180F) [24] have been
described. The triple mutant S57A/Y180F/S181 (TM)
was constructed by Genscript (Hong Kong) using the
DM plasmid as the template and introducing codon
TTC for F180. PGRMC1-HA open reading frames were
reconfirmed by DNA sequencing at Monash Micromon
DNA Sequencing Facility (Clayton, Vic., Australia) using
the 5′ T7 and 3′ BGH sequencing primers specific for
the parental vector. PGRMC1-HA plasmids were trans-
formed into Escherichia coli Top10 strain, and cultured
overnight at 37 °C on 1% agar plates containing Luria
broth (LB) media (Invitrogen) and 50 μg/mL ampicillin.
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A single colony was picked and bacteria were grown in
250 ml culture by aeration overnight at 37 °C in LB
media. Plasmid DNA was isolated by GeneJet Maxiprep
Kit (ThermoScientific) following the manufacturer’s
protocol. Plasmid DNA concentration was measured by
using Nanodrop (Thermo Scientific).
Cell culture
MIA PaCa-2 (MP) cell identity was verified as MIA PaCa-2
(ATCC CRL-1420) by the MHTP Medical Genomics Facil-
ity (Monash University, Melbourne) following the ATCC
Standards Development Organization document ASN-0002
for cell line identification via short tandem repeat profiling.
MP cells were maintained in Dulbecco’s Modified Eagle’s
medium (DMEM-high glucose, Sigma-Aldrich, D5796)
supplemented with 10% Foetal bovine calf serum (Sigma-
Aldrich, F9423) and 1% penicillin-streptomycin (Sigma-Al-
drich, P4333) (complete DMEM) at 37 °C and 5% CO2 in a
150i CO2 incubator (Heracell, Lane Cove NSW). Cell doub-
ling times were estimated by 3-(4,5-dimethylthiazolyl-2)-2,
5-diphenyltetrazolium bromide (MTT) assay or by Incu-
Cyte, as described [79]. Mitochondrial respiratory capacity
was measured using a Seahorse Extracellular Flux analyzer
XF24 (Seahorse Biosciences).
Transfection and stable cell line generation
Under our culture conditions, MP cells exist in culture
as flattened adherent cells of mesenchymal shape, a mi-
nority of rounded adherent cells, and a small population
of rounded suspension cells. Plating the suspension cells
regenerates a similar population distribution (not
shown). On the day before transfection, 2 × 106 MP cells
were seeded onto a 6-well plate. The cells were trans-
fected at 70–80% confluency. Before transfection, cells
were washed with Dulbecco’s phosphate-buffered saline
(PBS, Sigma-Aldrich, D8537) and maintained in
antibiotic-free Dulbecco’s Modified eagle Medium high
glucose (DMEM, Sigma-Aldrich, D5796) containing 10%
bovine calf serum (Sigma-Aldrich, 12133C) and 1% peni-
cillin/streptomycin (Sigma-Aldrich, P4458) (complete
DMEM). In separate transfections, 4 μg each of respect-
ive PGRMC1-HA plasmids (WT, DM or TM) and Lipo-
fectamine 2000 (Life Technologies, 11,668–019) were
mixed at 1:2 ratio and incubated for 25 min at room
temperature. The mixture was then added drop-wise to
the wells of the culture plate. After 6 h of incubation,
cells were washed with PBS and cultured at 37 °C and
5% CO2 in complete DMEM for 48 h, after which cells
were harvested and plated in three fold limiting dilution
in complete DMEM containing 50 μg/ml Hygromycin B
(EMD Millipore, 400,052) in 96 well plates. Cells were
cultured at 37 °C and 5% CO2 for 2 weeks, with regular
media changes containing complete DMEM with Hygro-
mycin B every 3 days to select for stable integration
events. Typically 8 independent stably transfected cell
lines were expanded for each of PGRMC1-HA WT, DM
and TM and 3 lines with similar levels of PGRMC1-HA
expression were selected by Western blot.
Cells were frozen 0.5–1.0 mL at − 80 °C in Bambanker
(Novachem, #306–14,684) at 2 × 106 cells/mL. Frozen
cells were introduced back into culture by thawing at
37 °C for 20 s followed by addition to 5 ml of complete
media and low speed centrifugation at 180 x g for 3
mins at 25 °C. Pelleted cells were resuspended in 6 mL
fresh complete media and seeded in 25 cm2 flasks.
Because of the dramatic effects observed, MP cells are
included in our experiments as a literature reference
point. MP differ from WT cells by not having undergone
hygromycin selection, and by lack of overexpression of
PGRMC1-HA. Therefore we cannot ascribe differences
between MP and WT cells to PGRMC1-HA expression.
The effects of the DM and TM PGRMC1 mutations are
assessed relative to WT control levels.
shRNA lentiviral production
Lentiviral-delivered shRNAs were constructed using Mis-
sion TRC2-pLKO-Puro series lentiplasmids (SHCLND,
Sigma-Aldrich) targeting ERR1/ESRRA (TRCN0000330191,
GAGAGGAGTATGTTCTACTAA), vinculin (shVCL)
(TRCN0000290168, CGGTTGGTACTGCTAATAAAT)
or non-target scrambled shRNA (shScr) (SHC202;
CAACAAGATGAAGAGCACCAA). MP and DM shVCL
cells were obtained at first attempt, however, despite three
attempts, WT cells could not be established. To generate
virus particles, we co-transfected HEK293 cells with the
shRNA plasmids and helper plasmids using Lipofectamine
2000 (Invitrogen, 11668-027). Prior to transfection, 6 well
plates were treated with 50 μg/mL D-Lysine overnight.
Next day, 1 × 106 HEK293 cells were seeded per well and
incubated overnight at 37 °C in complete medium. Trans-
fection mixture A contained 4 μg plasmid mixture consist-
ing of 2.5 μg target or shScr shRNA lentiplasmid, 0.75 μg
Pax, 0.3 μg Rev. and 0.45 μg VSV-G helper plasmids [80]
in 250 μL antibiotic-free medium. Transfection mixture B
contained 8 μL Lipofectamine and 242 μL antibiotic-free
medium. After 5min incubation at 25 °C, mixtures A and
B were gently mixed and incubated for 25min at 25 °C.
HEK293 culture medium was removed, cells were washed
with PBS, and 2mL fresh antibiotic-free medium was
added followed by addition of combined transfection mix-
ture to the cells, dropwise with gentle shaking, followed by
incubation for 6 h at 37 °C. After incubation, the medium
was replaced with complete medium overnight at 37 °C.
Virus particles were harvested by collecting culture
medium followed by the addition of new medium every
24 h for 72 h. Collected media for each culture were
pooled, filtered through a 22 μM filter, aliquoted into
1 mL fractions, and frozen at − 80 °C.
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shRNA lentiviral transduction
Briefly, 1 × 105 MP, WT, or DM cells per 24 plate well
were seeded in 1 mL complete DMEM medium and
grown to 60% confluency. The medium was removed,
and replaced by 1 mL of medium per well, containing 2-
fold serially diluted virus particles in adjacent wells, plus
5 μg/mL Polybrene (hexadimethrine bromide, Sigma-
Aldrich 107689) to enhance viral transduction. After
incubation for 24 h, the medium was removed and the
cells were washed twice with PBS after which fresh
medium was added supplemented with 1.5 μg/mL Puro-
mycin, which was replaced every 48 h for 1 week. Cells
from wells transduced with the lowest dilutions of
respective virus particles that survived selection were
expanded, and stocks frozen at − 80 °C in Bambanker.
Scratch migration assay
MP cells or stable transfected monoclonal MP cell lines
expressing PGRMC1-HA WT, DM or TM proteins (1 ×
104 cells) were seeded in a 24 well plate. The monolayer
of cells at more than 90% confluency was subjected to
serum starvation for 2 h. A scratch was created in the mid-
dle of the monolayer by a sterile p200 tip and washed
twice with PBS to remove floating cells. Complete media
was then added. The cell monolayer was incubated for 36
h to allow cell migration into the scratched area. Photo-
graphic images were taken at 0 and 36 h using an inverted
phase microscope (Nikon Eclipse Ti-U). Cells in the boxed
areas of Fig. 2a were manually scored from printed images.
Cell treatments included 125 nM Y-27632 dihydrochloride
(Abcam, ab120129, Rho Kinase inhibitor: ROCKI) or ve-
hicle control (DMSO). For video files the cells were incu-
bated at 37 °C and 5% CO2 for 36 h in a stage top
electrically heated chamber (Okolab H301-NIKON-
NZ100/200/500-N) including transparent heated lid
(H301-EC-HG-LID), with a 24-well Nunc/Greiner plate
base adapter (24MW-NUNC) and a chamber riser, for a
working distance of 28mm. The chamber was regulated
by a Control Unit (Okolab H301-TC1-HMTC) with
Digital CO2 controller (Okolab DGT-CO2 BX) and Air
Pump (Okolab, OKO-AP) and was inserted to a Nano-
Z100-N Piezo stage (Mad City Labs) on a motorized XY
stage (Nikon TI-S-ER). Images were taken every 10min
for 36 h with a 10× (0.45 NA) Plan Apo objective using
the transmitted light detector (TD) on a Nikon Ti Eclipse
Confocal microscope controlled by NIS Elements V4.10
software (Nikon).
Proteomics sample preparation
Three independent stable transfected lines of each
PGRMC1-HA-expressing cell type, as well as triplicates
of the MP parental cell line, were measured in technical
replicate data-dependent and independent data acquisi-
tion SWATH-MS modes on a 5600 TripleTof™ mass
spectrometer (ABSciex). Global proteomics analysis was
carried out at the Australian Proteome Analysis Facility
(APAF). Cells were grown in Wagga Wagga to 80% con-
fluency in 75 cm2 flasks. Three separate cultures of MP
cells (passages 8, 9 & 11) and three lines of each
PGRMC1-HA WT, DM and TM cells were used (inde-
pendent biological triplicates). Cells were harvested and
frozen cell pellets shipped on dry ice to APAF for Mass
spectrometric analysis. Cell pellets were lysed using
200 μL of sodium deoxycholate buffer (1% in 0.03M tri-
ethyl ammonium bicarbonate), and DNA digested using
0.5 μg of benzonase. Direct detect assay (EMD Millipore,
DDAC00010-8P) was performed on the samples and
100 μg of each sample was taken for digestion. Samples
were reduced with dithiothreitol (5 mM), alkylated with
iodoacetamide (10 mM) and then digested with 4 μg
trypsin for 16 h at 37 °C. The digested sample was acid-
ified and centrifuged to remove the sodium deoxycho-
late. Samples were then dried and resuspended in 100 μL
of loading buffer (2% acetonitrile 0.1% formic acid). Indi-
vidual samples for SWATH analyses were diluted 1:4
into loading buffer and transferred to a vial. Each sample
was measured in technical replicate. For IDA runs a pool
was made for each group (MP, WT, DM, and TM) by
taking equal portions from each biological replicate and
diluting 1:4 in loading buffer.
Proteomic information dependent acquisition
Tryptic peptides were analyzed on a 5600 TripleTof™
mass spectrometer (ABSciex). Chromatographic separ-
ation of peptides was performed on a NanoLC-2Dplus
HPLC system (Eksigent, Dublin, CA) coupled to a self-
packed analytical column (Halo C18, 160 Å, 2.7 μm,
75 μm× 10 cm). Peptide samples (4 μg of total peptide
amount) were loaded onto a peptide trap (Opti-trap Cap
0.5 mm × 1.3 mm, Optimize Technologies) for pre-
concentration and desalted with 0.1% formic acid, 2%
acetonitrile, at 10 μL/min for 5 min. The peptide trap
was then switched into line with the analytical column
and peptides were eluted from the column using linear
solvent gradients with steps, from 98% Buffer A (0.1%
formic acid) and 2% Buffer B (99.9% acetonitrile, 0.1%
formic acid) to 90% Buffer A and 10% Buffer B for 10
min, then to 65% Buffer A and 35% Buffer B at 500 nL/
min over a 78 min period. After peptide elution, the col-
umn was cleaned with 95% Buffer B for 15 min and then
equilibrated with 98% Buffer A for 15 min before the
next sample injection. The reverse phase nanoLC eluent
was subject to positive ion nanoflow electrospray ana-
lysis in an IDA mode. Sample analysis order for LC/MS
was DM1, DM2, DM2, DM3, DM3, MP2, MP2, MP3,
MP3, TM2, TM2, TM3, TM3, WT1, WT1, WT2, WT2,
WT3, WT3, DM1, MP1, MP1, TM1, TM1.
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In the IDA mode a TOFMS survey scan was acquired
(m/z 350–1500, 0.25 s), with the 10 most intense multi-
ply charged ions (2+ − 5+; counts > 150) in the survey
scan sequentially subjected to MS/MS analysis. The
selected precursors were then added to a dynamic exclu-
sion list for 20s. MS/MS spectra were accumulated for
50 milliseconds in the mass range m/z 100–1500 with
rolling collision energy.
Proteomic data independent acquisition (SWATH)
Samples were analyzed by SWATH-MS [81] proteomics
profiling in duplicate, with the chromatographic condi-
tions as for IDA analysis above. The reverse phase
nanoLC eluent was subject to positive ion nanoflow
electrospray analysis in a data independent acquisition
mode (SWATH). For SWATH MS, m/z window sizes
were determined based on precursor m/z frequencies
(m/z 400–1250) in previous IDA data (SWATH variable
window acquisition, 60 windows in total). In SWATH
mode, first a TOFMS survey scan was acquired (m/z
350–1500, 0.05 s) then the 60 predefined m/z ranges
were sequentially subjected to MS/MS analysis. MS/MS
spectra were accumulated for 96 milliseconds in the
mass range m/z 350–1500 with rolling collision energy
optimized for lower m/z in m/z window + 10%. To
minimize instrument condition caused bias, SWATH
data were acquired in random order for the samples
with one blank run between every sample.
SWATH library generation
The LC-MS/MS data of the IDA data were searched
using ProteinPilot (version 4.2) (Sciex) and combined
into a single search report file. The files were searched
against Human entries in the Swissprot 2014_04 data-
base (released 16/04/2015, containing 545,388 entries).
The search parameters were selected as follows: iodoace-
tamide cysteine alkylation, trypsin digestion, Triple TOF
5600 instrumentation, biological modifications, thorough
search and false discovery rate enabled.
SWATH data processing
SWATH data were extracted using PeakView (version
2.1, Sciex) with the following parameters: Top 6 most
intense fragments of each peptide were extracted from
the SWATH data sets (75 ppm mass tolerance, 10 min
retention time window). Shared peptides were excluded.
After data processing, peptides (max 50 peptides per
protein) with confidence ≥99% and FDR ≤1% (based on
chromatographic feature after fragment extraction) were
used for quantitation. The extracted SWATH protein
peak areas were normalized to the total peak area for
each run and subjected to t-test to compare relative pro-
tein peak area between the samples. Protein t-test with
p-value smaller than 0.05 and fold change larger than
1.5 were highlighted as differentially expressed. The ana-
lysis of four different cell types was treated as six separ-
ate paired comparisons: 1) MP vs. WT, 2) MP vs. DM,
3) MP vs. TM, 4) WT vs. DM, 5) WT vs. TM, and 6)
DM vs. TM. Additionally, a similar method for deter-
mining differential expression was run at the peptide
level, with the peptide level fold changes then
averaged for each protein. The peptide level analysis
is more conservative, as peptide level p-values are
only generated when a protein was identified by at
least two proteins. Peptide level data were used for
this study.
WebGestalt enrichment analyses
Gene Ontology (GO) and pathway enrichment analysis
were conducted on differentially abundant proteins from
Figure S2D using the WEB-based GEne SeT AnaLysis
Toolkit (WebGestalt) platform (http://bioinfo.vanderbilt.
edu/webgestalt/) [82]. Figures or Supplementary Figures
depicting or relying on WebGestalt results describe sup-
plementary data files available online that contain the re-
spective original WebGestalt analysis files. Attempting
to identify the most important driving contributions to
the phenotypic alterations observed, a complementary
WebGestalt analysis was also performed at the adjP<
0.001% level, but employing the subsets of proteins
which were detected to be either significantly up- or
down-regulated (“red” and “blue” lists of proteins for
each comparison from File S1). The UniProt protein IDs
from respective proteomics comparisons were uploaded
as text files which accompany the respective WebGestalt
supplementary data files. KEGG, Pathway Commons,
and Wiki Pathways were analyzed at the 5% level. GO
and transcription Factor analyses were also performed
for comparisons of differentially up- or down-regulated
proteins for each pair-wise comparison between cell
types at the 0.1 and 10% levels. The following WebGes-
talt settings were employed: Organism: hsapiens; gene Id
Type: entrezgene; Reference Set for Enrichment Ana-
lysis; entrezgene_protein-coding; Significance Level:
(variable see individual analysis descriptions), Statistical
Method: Hypergeometric, Multiple Test Adjustment:
Benjamini-Hochberg (BH), Minimum Number of Genes
for a Category: 3.
Pathway enrichment analyses can consider either a) all
differential proteins together (including both up- and
down-regulated proteins in the one analysis), or b) can
examine the higher abundance and lower abundance
proteins in separate analyses for each comparison (“red”
or “blue” analyses for each comparison). Our WebGes-
talt pathway analysis strategy of Fig. 3 pursued the sec-
ond of these alternatives. In the first analysis, all proteins
found to be differential (both up- and down-regulated)
between two samples in any six of the analyses were
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entered as a protein list to WebGestalt, and pathway en-
richment analysis was performed with multiple sample
correction at the Benjamini and Hochberg (BH) adjusted
p (adjP) significance level of 0.001 for KEGG, Pathway
Commons, and Wikipathways for each of the six basic
cell-type comparisons.
Twelve separate WebGestalt analyses were performed
for Fig. 3, with enrichment analyses including KEGG,
PC, WikiPathways, as well as Transcription Factor and
GO cellular component. The schematic representation
of Fig. 3 shows pathways identified as significantly
enriched for at least one of 12 comparisons (6x more
abundant “red” and 6x less abundant “blue”) between 1)
MP vs. WT, 2) MP vs. DM, 3) MP vs. TM, 4) WT vs.
DM, 5) WT vs. TM, and 6) DM vs. TM. The pathway
mapping for all significantly detected features between
all comparisons detected at adjP< 0.001 is available as
File S5A. Another WebGestalt analysis was performed at
adjP< 0.1 and the significances of each pathway identi-
fied in File S5A at the adjP< 0.001 level were then re-
corded for all comparisons at the adjP< 0.1 level in File
S5B. The analysis results are presented for reference as
File S4B. That information was used to assign statistical
significance in the pathways map for all features that
were identified at the adjP< 0.001 level in any one com-
parison, across all 12 comparisons at the adjP< 0.1 level.
These data were then used to map all proteins from all
pathways and all comparisons of File S5B to produce the
original image of Fig. 3 in Microsoft Excel, which is
available as File S6 and contains all protein and pathway
identities.
Mapping pathways to the expression heat map
The matrix of protein membership to pathway or func-
tional group category is a resulting sparse matrix with 0/
1 indicating that the respective protein is/is not present
in the respective category. This matrix was clustered
using the hclust implementation in the R Base Package
(www.r-project.org/), using a binary distance and
complete linkage, to reorder the columns (pathways in
this case) according to the proportion of shared proteins.
The resulting cladogram including overlapping features
identified by all WebGestalt analyses appears to the right
of pathways in Fig. 3, and with complete accompanying
protein and pathway identities in File S5.
Principal components analysis on proteomics results
Principal component analysis was used to examine
the largest contributions to variation in the protein
measurements. Wilcoxon rank-sum tests were used
to identify the pathways that were positively or
negatively associated with the principal component
scores.
Sample preparation for Western blots
Approximately 70% confluent cells in a T75 flask were
washed twice with chilled PBS buffer and incubated with
500 μL radio immunoprecipitation assay buffer (RIPA
buffer) (Sigma-Aldrich, R0278) supplemented with pro-
tease and phosphatase inhibitor cocktail (Thermoscienti-
fic, 88668) following manufacturer’s recommendations.
After scraping, the lysate was centrifuged at 8000 g for
20 min (Hermle Centrifuge Z233 M-2) at 4 °C. Protein
concentration was determined using the Pierce BCA
protein assay kit (ThermoFisher, 23225) following the
manufacturer’s instructions. Twenty microgram cell ly-
sates were each mixed with 2x Laemmli loading buffer
(Sigma-Aldrich, S3401) at a 1:1 ratio to give final volume
20 μL, followed by denaturation at 95 °C for 5 min in a
digital dry bath heater. Lysates were loaded immediately
to a 10% SDS-PAGE gel. For HA western we used 17
well gels (Life technologies, NW04127), for PGRMC1
Western blots we used 15 well gels (Bio Rad. 456–1069),
for vinculin and ERR1 Western blots we used 10 well
gels (Bio Rad 456–1096). Electrophoresis was at 150 V
for 45 min. Protein was transferred onto PVDF mem-
branes (Bio-Rad, 1620174) with a Trans-Blot Turbo
transfer system (Bio-Rad, Gladesville NSW) for 7 min by
Trans-Blot® Turbo RTA Mini LF PVDF Transfer Kit
(Bio-Rad, 1704274) or wet transferred in 25 mM Tris,
192 mM glycine, 20% (v/v) methanol (pH 8.3) (1x Tow-
bin buffer) at 20 V for 2.5 h on mini trans-blot cell (Bio
Rad, 1703930) cooled on ice.
Western blots
Membranes were blocked with TBS-T (0.1% Tween-20
in 1× Tris-buffered saline) containing 5% Woolworths
Instant Skim Milk Powder (Woolworths, Wagga Wagga,
NSW, Australia) for 1 h and incubated overnight at 4 °C
with primary (1°) antibody. After washing 3 times with
TBS-T, blots were incubated with secondary (2°) anti-
body for 1 h at room temperature. Proteins were de-
tected by the following methods. For chemiluminescence
detection the membranes were incubated with Clarity
Max Western ECL Substrate (Bio-Rad, #1705062) for 5
min for detection by enhanced chemiluminescence using
a Bio-Rad ChemiDoc MP imaging system (Bio-Rad, Gla-
desville NSW). Fluorescence detection was performed
on the ChemiDoc (at the indicated wavelength). Molecu-
lar weight standard proteins for gels imaged for fluores-
cence or chemiluminescence were detected on the
ChemiDoc using the IRDy680 channel. Colorimetric de-
tection (Vinculin and ERR1 Western blots) was per-
formed by incubation of membranes with 3 mL
Tetramethylbenzidine (TMB) (Sigma-Aldrich, T0565)
for 5 min. These images were captured by Molecular
Imager Gel Doc XR+ System (Bio-Rad, Gladesville
NSW). Multi-channel ChemiDoc images were generated
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with the Bio-Rad Image Lab Software. Some dual chan-
nels images were manipulated in Adobe Photoshop CC
2018 (Adobe Systems Inc.) by reducing intensity in ei-
ther red or green channel to lower background in the
published image. Adjustments were applied identically
over all image pixels so as to not alter the relative inten-
sities of any bands.
The following primary (1°) and secondary (2°) antibody
pairs were used (at the specified dilutions) with the indi-
cated detection methods. For PGRMC1 Western: 1° goat
anti-PGRMC1 antibody (Abcam, ab48012) (1:1000) and
2° rabbit anti-goat secondary antibody (Abcam, ab6741)
(1:4000) detected by chemiluminescence. After detec-
tion, membranes were blocked with TBS-T overnight
and then incubated with 1° mouse anti-beta actin
(Sigma-Aldrich, A5541) (1:2000) and 2° goat anti-mouse
IgG H&L (IRDye 800CW) (1:5000) detected by fluores-
cence (IRDye 800CW). For HA epitope Western: 1°
mouse anti-HA (Sigma-Aldrich, H3663) (1:2000) and 2°
goat anti-mouse IgG H&L (IRDye 800CW) (dilution 1:
5000) detected by fluorescence (IRDye 800CW), as well as
1° rabbit anti-beta-actin (Cell Signaling, 4967) (1:2000)
and 2° donkey anti-rabbit IgG (Abcam, ab16284) (1:2000)
detected by chemiluminescence. For vinculin Western: 1°
anti-vinculin (E1E9V) XP (Cell Signaling Technology, 13,
901) (1:1000) and 2° donkey anti-rabbit IgG (Abcam,
ab16284) (1:2000) detected colorimetrically. For ERR1
Western: 1° rabbit anti-ERRα (E1G1J) (Cell Signaling,
13826S) (1:1000) and 2° donkey anti-rabbit IgG (Abcam,
ab16284) (1:2000) detected colorimetrically.
Reverse Phase Protein Array analysis
RPPA arrays using Zeptosens technology (Bayer AG, Le-
verkusen, Germany) were used for analysis of signaling
protein expression and activity profiling as described [83–
86]. For the analysis, flash frozen cell pellets were lysed by
incubation with 100 μl cell lysis buffer CLB1 (Bayer,
Germany) for 30min at room temperature. Total protein
concentrations of the lysate supernatants were determined
by Bradford Assay (Coomassie Plus, Thermo Scientific).
Cell lysate samples were adjusted to uniform protein con-
centration in CLB1, diluted 10-fold in RPPA spotting buf-
fer CSBL1 (Bayer) and subsequently printed as series of
four dilutions (starting concentration at 0.3 μg/μl plus 1.6-
fold dilutions) and in two replicates each. All samples
were printed as replicate microarrays onto Zeptosens
hydrophobic chips (Bayer) using a NanoPlotter 2 (GeSim,
Grosserkmannsdorf, Germany) applying single droplet de-
positions (0.4 nL volume per spot). After printing, the mi-
croarrays were blocked with 3% w/v albumin, washed
thoroughly with double distilled H2O, dried in a stream of
nitrogen and stored in the dark at 4 °C until further use.
Protein expression and activity levels were measured
using a direct two-step sequential immunoassay and
sensitive, quantitative fluorescence read-out. A single
array was probed for each protein. Highly specific and up-
front validated primary antibodies were incubated at the re-
spective dilution in Zeptosens assay buffer overnight (15 h)
at room temperature. Arrays were washed once in assay
buffer and incubated for 45min with Alexa647-labeled
anti-species secondary antibody (Invitrogen, Paisley, UK).
Arrays were then washed as before and imaged using a
ZeptoREADER instrument (Bayer) in the red laser channel.
Typically, six fluorescence images were recorded for each
array at exposure times of between 0.5 and 16 s. Negative
control assays incubated in the absence of primary antibody
(blank assays) were also performed to measure the non-
specific signal contributions of the secondary antibody. In
addition, one chip out of the print series was stained to
measure the relative amount of immobilized protein per
spot (protein stain assay). The following primary antibodies
(provider and reagent number, dilution) were used: BAD
(CST 9239, 1:200), BAD-P-Ser112 (CST 5284, 1:100),
BAD-P-Ser136 (CST 4366, 1:100), FAK1-P-Tyr577 (Invi-
trogen 44-614ZG, 1:100), FAK1-P-Tyr861 (Epitomics
2153–1, 1:100), GSK3beta (CST 9315, 1:200), GSK3beta-P-
Ser9 (CST 9336, 1:100), HSF1 (Epitomics 2043–1, 1:1000).
After assay measurements (one protein per array), array
images and data were analyzed with the software Zepto-
VIEW 3.1 (Bayer). For each array/antibody, the image taken
at the longest exposure time without showing any satur-
ation effect was analyzed with the spot diameters set to
160 μm. Mean fluorescence signal intensity (MFI) of each
sample was calculated from referenced, background-
corrected mean intensities of the single spots (eight spots
per sample) applying a linear fit and interpolating to the
mean of the four printed protein concentrations. Blank-
corrected MFI signals of the samples were normalized for
the relative protein concentration printed on the chip to
obtain normalized fluorescence intensity signals (NFI). NFI
values were used for all subsequent statistical analyses.
Glucose uptake & lactate production assay
Glucose uptake and lactate production assays were per-
formed by using commercially available kits from Cayman
chemical (#600470, #700510) following manufacturer’s
protocols. Glucose uptake was measured with a Fluostar
Omega fluorescence microplate reader (BMG Labtech,
Ortenberg, Germany) and lactate production was
quantified with a Molecular Devices Spectra Max 190
microplate reader (Bio-Strategy P/L, Campbellfield,
Vic., Australia).
NpFR2 redox assay
Intramitochondrial redox status was determined using
naphthalimide flavin redox sensor 2 (NpFR2) [48]. Mia
PaCa-2 and PGRMC1-HA-expressing stable cells (1 ×
106) were suspended in 2 mL complete media and
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seeded in six well plates and cultured for 24 h at 37 °C
and 5% CO2. Cells were washed with PBS, trypsinsed,
harvested, and resuspended in 1 mL of fresh media con-
taining 25 μM NpFR2 in a 1.5 mL microcentrifuge tube,
followed by incubation for 20 min at 37 °C. Cells were
then centrifuged in a microcentrifuge at 180 x g, the pel-
let was resuspended once with 1 mL PBS followed by
recentrifugation, and the washed pellet was again
resuspended in 1mL PBS. Five hundred microliter cell
suspension was loaded to a Gallios Flow Cytometer
(Beckman Coulter) and fluorescence of 2 × 104 cells was
detected using FL1 (green) channel.
Immunofluorescence microscopy
To detect the expression of exogenous HA tagged
PGRMC1 in Fig. 1e, cells were seeded on coverslips on a
six well plate. The cells were washed with ice-cold PBS,
mildly fixed with 3.7% formaldehyde for 5 min at 4 °C.
The cells were then permeabilized with ice-cold 100%
methanol for 10 min at − 20 °C, followed by overnight
incubation with anti-HA tag antibody (Sigma, H3663).
The cells were washed extensively and incubated with
FITC conjugated secondary antibody (Sigma, F8521) in
dark for 1 h at 4 °C. Cells were washed three times with
PBS and counterstained with DAPI mounting solution.
Images were captured using a Nikon Ti Eclipse Confocal
microscope (Nikon Australia Pty Ltd).
Analysis of mitochondrial morphology
Mitochondria were quantified for cell shape (elongated/
round), mitochondrial content (sum of mitochondrial
area/cell), mitochondrial size (average perimeter/cell),
and mitochondrial morphology or Formfactor (FF): a
measure where higher values correspond to a greater
level of filamentous mitochondria and lower values cor-
respond to more highly fragmented mitochondria [52].
FF (calculated as the P2/4πA) measures mitochondrial
morphology based on the perimeter and area of shape.
The calculation takes in to account not only changes in
length, but also the degree of branching, making at an
ideal form of measurement for the quantification of
mitochondrial morphology.
To measure FF, 1 × 105 cells were seeded onto Nunc
176740 four well plates with a 22x22mm #1.5 glass
coverslip on the bottom. Cells were fixed and perme-
abilized as above, then incubated with Abcam mouse
anti-mitochondrial IgG1 antibody (Abcam ab3298) and
then with FITC-conjugated goat anti-mouse secondary
antibody (Sigma-Aldrich F4018) and DAPI, followed
phalloidin red staining and imaged with 3D-Structured
Illumination Microscopy (SIM) on a DeltaVisionOMX
Blaze microscope as described [87]. Images were proc-
essed using Fiji/ImageJ software [88], and Area and
Perimeter values were extracted to calculate form factor.
Cell morphology was scored as either ‘round’ or ‘elon-
gated’ by JCC as part of the mitochondrial quantification
process.
Holo-tomographic imaging
Holo-tomographic video imaging was performed on a
NanoLive (Switzerland) 3D Cell Explorer fluo (AXT Pty
Ltd., Warriewood, NSW) equipped with a NanoLive live
cell incubator (AXT Pty Ltd). 1 × 104 cells were seeded
into a FluoroDish cell culture dish 35 mm, 23 mm well
(World Precision Instruments, FD35) and maintained in
phenol red free DMEM medium (Sigma-Aldrich, D1145)
supplemented with 10% fetal bovine calf serum (Sigma-
Aldrich, F9423), 2 mM glutamine (Sigma-Aldrich,
G7513) and 1% penicillin-streptomycin for 48 h. Imme-
diately prior to imaging the medium was removed and
replaced with 400 μL of the same medium, followed by
transfer to the live cell incubator chamber of the 3D Cell
Explorer. Cells were incubated at 37 °C, 5% CO2 and
100% humidity for the duration of the time-lapse. Three
dimensional holo-tomographic images were captured
every 20 s for the duration of the time-lapse using the
Nanolive STEVE software. For File S7 the center plane
of each 96 slice stack was exported after capture using
the built in STEVE export wizard as an .avi movie file.
These files were exported at 5 frames per second (100x
actual speed) to visualize cellular dynamics.
Subcutaneous mouse xenograft tumors
Animal experiments and welfare conformed to the Aus-
tralian National Health and Medical Research Council
guidelines and institutional ethics approval from the
Animal Ethics Committee at the Australian National
University (E2017/16) and Charles Sturt University
Animal Care and Ethics Committee (A17046). NOD/
Shi-SCID/IL-2Rγnull (NSG) mice were bred and sup-
plied by the Australian Phenomics Facility at the Austra-
lian National University (ANU), an Australian academic
center funded by the Australian Government’s National
Collaborative Research Infrastructure Strategy (NCRS)
program, and contributions from ANU. Experiments
were performed in the John Curtin School of Medical
Research satellite animal facility. Animals were housed
in individually ventilated cages with access to food and
water ad libitum, enriched with corn cob bedding and a
maximum of 5 mice per cage. Animals were injected in
four cohorts randomized by weight, and the number of
mice per cohort was based on availability. Mice were
injected with independently generated cell lines MP,
WT1-WT3, DM1-DM3, TM1-TM-3, and Y180F. Cells
were expanded in culture for a maximum of 2 weeks be-
fore injection. Cells were trypsinized, pelleted, washed
with PBS and stored on ice. Cell count was determined
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using a hemocytometer and trypan blue. Two million
cells were resuspended in 100 μL 50:50 Matrigel:PBS for
sub-cutaneous injection into the left flank of female
NSG mice (8–12 weeks) via a 27-gauge needle. The total
number of mice injected per cell line was based on the
replicate coefficient of variation (CV) for solid tumour
models evaluating disease burden = 10%, CV being the
measure of spread that describes the amount of variabil-
ity relative to the mean. A t-test-based statistical analysis
of simulated differences in mean tumour progression
shows that a minimal number of replicates of n = 10 is
necessary to identify a greater than or equal to 20%
change between replicate groups at a pre-determined
statistical significance level of 5%. However this was re-
fined in order to reduce animal usage where possible ac-
cording to the NHMRC Australian code for the care and
use of animals for scientific purposes. For cohort 1 four
animals each were injected with MP, WT1, DM1, and
TM1. For cohort 2 four animals each were injected with
WT2, DM2 and TM2, and one animal with MP. For co-
hort 3 four animals each were injected with WT3, DM3
and TM3, one animal with MP. For cohort 4 five ani-
mals were injected with Y180F cells, and one animal
with each of MP, WT1, DM1, and TM1. Injection of each
cohort commenced mid-morning. Mice were monitored
daily and once the tumor was palpable (~ 2.5–4 weeks),
tumor growth was measured 3 times a week using calipers
until at least one tumor in the cohort reached 1 cm3 in
volume. Once any animal in any group in the cohort
reached the maximum size of tumor all animals were
euthanized for tissue recovery by cervical dislocation and
tumors were harvested, weighed, photographed, and fixed
with formalin.
Statistical analyses
Unless specified otherwise, statistical analysis was
performed using the SPSS package (IBM). Results for
WT, DM and TM cells represent equal numbers of
three independently derived cell lines for each
PGRMC1 condition (e.g. n = 6 for WT includes 2x
WT1, 2xWT2, and 2xWT3). For boxplot data depic-
tions, whiskers represent quartiles 1 and 4 (with
maximum and minimum values). Boxes represent
quartiles 2 and 3, separated by the median, as gener-
ated by SPSS analyze data function. Datasets con-
forming with normal distribution were analyzed by
ANOVA and post-hoc Bonferroni or Tukey HSD test
(equal variance) or post-hoc Dunnett’s T3 Test (un-
equal variance). Statistical differences between diver-
gent treatments of different cell lines were calculated
using two way ANOVA and post-hoc pairwise com-
parisons. For non-parametric data sets Kruskal-
Wallis or Kolmogorov-Smirnov tests were performed,
as indicated in relevant figure legends.
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Additional file 1: Figure S1. Detailed views of selected pathways
identified by WebGestalt analyses. Related to Fig. 3. All panels are
adapted from File S6. Heat map colors follow Fig. 3. (A) Principal
component (PC) analysis of SWATH-MS proteomics results showing distri-
bution of PC1 and PC2. PC1 corresponded to pathways associated with
ribosomes and translation, while PC2 corresponded to pathways associ-
ated with mRNA splicing processing (see File S3). (B) Proteins associated
with PI3K/AKT activity (WebGestalt Database: PC, DB_ID:1648, “Class I PI3K
signaling events mediated by AKT”) are less abundant in TM cells. (C) F1/
F0 ATPase subunits elevated in WT and TM cells. (D) Abundances of pro-
teins associated with protein folding and microtubule function are altered
by PGRMC1 phosphorylation status. Proteins detected in any of the fol-
lowing WebGestalt pathways or functions (1–4) or a manual search (5)
are mapped against their expression profiles. 1) cellular component
chaperonin-containing T-complex GO:0005832. 2) PC pathway
Chaperonin-mediated protein folding DB_ID:710. 3) cellular component
microtubule GO:0005874. 4) PC pathway Protein folding DB_ID:712. 5)
Description from the list of 243 proteins (File S6) contains keywords
“tubulin” or “microtubule” (manual search) (Adapted from File S6). 2-tailed
t-test p-values for all sample comparisons are available in File S4. (E) Pro-
teins associated with nuclear import/export that are elevated in DM cells.
(F) Antigen processing and presentation enzymes are affected by
PGRMC1 phosphorylation status. Manual additions to KEGG pathway
ID:04612 “Antigen processing and presentation" (no yellow shading: from
File S6 and File S5) are indicated with yellow highlighting. Figure S2.
Highest and lowest differentially abundant proteins. Panels show the six
most (+) and least (−) abundant proteins for each cell type that were sig-
nificantly differentially abundant between cell types. Related to Fig. 3.
Identical colored symbols depict the same protein in different cell types,
where circles represent high abundance and triangles represent low
abundance. E.g. Mitochondrial import receptor subunit TOM40 (O96008),
CDP-diacylglycerol-inositol 3-phosphatidyltransferase (CDIPT, O14735)
(phosphatidylinositol synthesis) and transcriptional coactivator PSIP1
(O75475) are more abundant in WT and TM. Aldehyde dehydrogenase
1A3 (P47895), APOC3 (P02656) and APOA1 (P02647) are less abundant in
DM and TM, whereas the receptor tyrosine kinase ephrin type-A receptor
2 (EPHA2, P29317) is among the lowest abundance differential proteins in
WT and TM. Protein abundances (measured ion intensities) for all proteins
are available in File S2. Figure S3. Proteins associated with predicted Es-
trogen Receptor Related 1 (ERR1) transcription factor activity are more
abundant in WT and TM cells. Related to Fig. 3 and File S6. Data are avail-
able via ProteomeXchange with identifier PXD014789. (A) Proteins quanti-
fied by SWATH-MS and predicted by WebGestalt Transcription Factor
target enrichment analysis (WebGestalt Database: Transcription Target,
Name: hsa_TGACCTY_V$ERR1_Q2, ID:DB_ID:2414) to be dependent upon
ERR1 transcription (Adapted from File S6). Heat map colors follow Fig. 3.
(B) Western blot of shRNA attenuation of ERR1 (top panel) in WT cells,
compared to scramble shRNA control. Lower panel: beta actin loading
control. (C) ERR1 attenuation by shRNA induces morphological changes
to WT cells. (D) Ratio of rounded to other cells as scored for replicate im-
ages from each of the cell lines from B. p < 0.0005, 1 tailed t-test. (E)
SWATH MS quantification of proteins significantly differentially abundant
between cells expressing scramble shRNA or anti-ERR1 shRNA (according
to the selection criteria of File S4). Fifty-seven proteins became more
abundant after shRNA depletion of ERR1, and 19 proteins became less
abundant. In this panel green depicts lower abundance and red depicts
higher abundance. Brown depicts similar abundance. (F) Proteins present
in (E) which are also present in the 243 protein list of File S6. Heat map
colors follow Fig. 3. The left panel shows expression in the original result
of File S6. The right panel shows expression in the presence of scramble
shRNA or anti-ESSR1 shRNA. All proteins from Fig. S3A except Q9BPW8
were detected in the shRNA experiment. Double headed arrows indicate
proteins which differ in expression tendency between WT (left) and WT-
scramble shRNA cells (right). This may be caused by the puromycin selec-
tion of both sh-scr and shERR1 cells but not the parental WT cells, how-
ever this requires further investigation. Proteins with Uniprot ID
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highlighted by asterisk (bold red) are those both originally predicted by
WebGestalt to be associated with ERR1 transcription factor (A), and which
exhibited significantly altered abundance after shRNA attenuation of
ERR1 protein. Figure S4. The DM migratory phenotype is dependent
upon Vinculin. Related to Fig. 3. (A) Proteins associated with actin-myosin
contraction (WebGestalt Database: PC, DB_ID:144, “Smooth Muscle Con-
traction”) are more abundant in DM cells. Heat map colors follow Fig. 3.
(B) Western blot of Vinculin (VCL) and actin levels in cells expressing
scramble control (shScr) or anti Vinclulin (shVNC) shRNA. (C) Scratch as-
says as indicated were performed following the methods of Fig. 1e-f. (D)
Boxplot showing results of 12 replicates of (C). ANOVA gave F = 78.7, p <
0.00001. The table shows post-hoc Dunnet’s T3 p-values. Figure S5.
PGRMC1 phosphorylation status affects mitochondrial function. Related
to Fig. 5. (A) Representative flow cytometry results of cells labeled with
NpFR2. The percentage of the cell population to the right of the dashed
reference line (interval labeled “B”, marked by the dotted line) is quanti-
fied for each measurement. White arrows indicate more oxidized NpFR2
fluorescence in WT and TM cells. (B) Boxplots of the percentage of cells
exhibiting > 10 fluorescent intensity units to the right of the reference
line in (A). n = 6 for each cell type, being 6 replicates of MP cells, or dupli-
cate measurements of each of 3 independent lines 1–3 (n = 3 × 2 = 6) for
WT, DM and TM cells. White arrows indicate the same differences as in
(A). There was significant difference between the means (Kruskal-Wallis
Test p < 0.0001). Independent sample median tests revealed that all me-
dians were significantly different from one another (p < 0.001). (C) Repre-
sentative flow cytometry results of cells labeled with MitoTracker. The
respective panels depict fluorescence intensity (x axis) plotted against ei-
ther side scatter (left/black plots) or cell number (right/red plots), with or
without the addition of MitoTracker as indicated. MitoTracker affinity for
mitochondria is increased with higher mitochondrial membrane potential
(Δψm), such that respective left MitoTracker-treated populations/peaks
represent low Δψm populations, and respective right MitoTracker-treated
populations/peaks represent high ψm populations. Vertical dotted lines
for Mitotracker-treated cells depict the MFI for MP cell low and high
Δψm populations. The black arrow for DM cells with Mitotracker high-
lights reduced MFI of both the low and high Δψm DM cell populations.
The white arrow highlights the reduced proportion of DM cells in the
low Δψm peak. The same arrows are depicted for replicates in (D) and (E)
respectively. (D) Median Fluorescent Intensity (MFI) for each of the cell
populations observed from (C). n = 6 measurements per cell type, as per
(B). Error bars depict standard deviation. The low and high Δψm popula-
tions correspond to the respective populations from (C). For low Δψm
cells the means were significantly different between cell types (ANOVA,
post-hoc Dunnet’s T3, p < 0.003). For high Δψm cells WT vs. TM (p < 0.05)
and other comparisons (p < 0.004) were significantly different (Kruskall-
Wallis). Tables D(L) and D(H) show pairwise comparison p-values for low
Δψm (F(L)) and high Δψm (F(H)) cells. (E) The percentage of cells in each
of the low and high Δψm populations from (C) and (D), from the same
data. Standard deviation error bars for the respective high Δψm (upper
error bar) and low Δψm (lower error bar) cell populations are given for
each cell type. Color-coding and all other terminology follows (C). For
low Δψm cells, Shapiro-Wilk’s test showed normal distributions, and
Levene’s test revealed non-homogenous variance (p = 0.04). Table E
shows p-values for ANOVA/post-hoc Dunnet’s T3 test pairwise compari-
sons. (F, G) Area under curve (AUC) plots for basal and FCCP curves from
(Fig. 5c) showing one way ANOVA/post-hoc Bonferroni p-values between
samples in the respective indicated regions.
Additional file 2: File S1. A zip archive containing time lapse mp4
movies of migrating cells in scratch assays. Related to Fig. 1. Images were
taken at 10 min intervals over 36 h and are replayed over 65 s at 9 frames
per second (2000x real time). The presented 32.4 MB MP4 files were
generated from the original 666 MB (6000x real time) .avi files (length 21
s, frame width x height 1024 × 1024, Data rate/bit rate 287,462 kbps,
frame rate 100 fps) by processing in Adobe Premiere Pro 2017 using the
following settings: Preset “custom”; Width: 1024; Height 1024; Aspect
Square Pixels (1.0); Field Order: progressive; Profile: high; Target Bitrate
[Mbps] 4.08; Maximum Bitrate [Mbps] 4.39; 9 fps; No Audio; Output as
standard .mp4; Time Interpolation: Frame Sampling; Stream Compatibility:
Standard; Variable bit rate, single pass; Number of frames 00:01:04:09. The
zip archive contains 4 files with filenames representing cell type and date
of measurement (yyyymmdd). (A) A_MP_20170807.mp4. (B)
B_WT_20170809.mp4. (C) C_DM_20170815.mp4. (D)
D_TM_20170817.mp4.
Additional file 3: File S2. An Excel file showing experimental design,
normalized ion intensities for 1330 proteins identified by SWATH-MS pro-
teomics, and six pairwise comparisons between the 4 sample types [1)
MP v. WT, 2) MP v. DM, 3) MP v. TM, 4) WT v. DM, 5) WT v. TM, and 6) DM
v. TM]. Related to Fig. 3. The first tab contains a detailed descriptive le-
gend. Data are available via ProteomeXchange with identifier PXD014716.
Additional file 4: File S3. Principal component analysis results for
pathways associated with SWATH-MS proteomics results.
Additional file 5: File S4. An excel file containing proteomics results
for 243 proteins which fulfil stringency criteria of t-test p-value of less
than 0.05, and a fold change greater than 1.5 by both the protein and
peptide approaches from File S2. Related to Fig. 3. Column B shows “red”
(more abundant in comparative sample 1) and “blue” (less abundant in
sample 1) significantly differential proteins for each pair wise comparison
which were later used for “red” and ‘blue” WebGestalt pathways enrich-
ment analysis (File S5). Comparisons follow File S2.
Additional file 6: File S5. WebGestalt pathway mapping excel results
file for red and blue proteins from File S4. Related to Fig. 3. (A)
WebGestalt Features (GO, KEGG Pathways, Wikipathways, Pathway
Commons, Transcription Factors) significant at the adjP≤0.001 level
between any 2 comparisons. (B) Features from A, viewed at the adjP<
0.05 level for each red and blue comparison, and showing adjusted p-
values (adjP) for each comparison where adjP< 0.05 (or adjP< 0.1 for two
comparisons as indicated by paler coloring). Blue means that proteins
associated with a given the feature were less abundant in that cell line,
with red indicating higher abundance. Because separate WebGestalt
analyses were performed for red and blue lists of proteins from File S4,
some features were significant for both red and blue. In that case the
color and adjP for the most significant analysis is given, with the other
cell being colored black.
Additional file 7: File S6. An excel file with heat map protein IDs and
pathways for red vs. blue pathways adjP< 0.001. Related to Fig. 3. This file
is derived from the results of File S5, and is the source file for Fig. 3.
Proteins suggested by clustering by inferred models of evolution (CLIME)
analysis to co-evolve with PGRMC1 with log likelihood ratio greater than
12 [21] are present in the list, marked yellow for mitochondrial
localization (WebGestalt GO:0005739) or green for cytoplasmic (P00387).
Additional file 8: File S7. A zip archive containing time lapse Holo-
tomographic video.avi files of cells. These images are based upon differ-
ences in refractive index [53], and are provided for the dynamic
visualization of mitochondria. Prominent visible features include small
white lipid droplets and cholesterol-rich mitochondria [21], as well as nu-
clear membrane and nucleoli. The previously described MIA PaCa-2 cell
bleb-like protrusions [34] are apparent as highly dynamic rearrangements
of the cytoplasmic membrane, which may contribute to intercellular
communication. (A) MP cells. (B) WT cells. (C) DM cells. (D) TM cells.
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